Farmaforum Partnering Day 2025

18 Sept 2025 | Madrid, Spain

Register
Register
Register

Veos Pharmaceuticals, SL

SME

www.veospharma.comMadrid, Spain

About

Veos Pharmaceuticals is a science-driven biotech company developing clinically validated, natural health solutions for aging, performance, metabolism, and immunity.

Our pipeline includes:

  • ThymoTropin™ – the world’s first natural myostatin-regulating ingredient for muscle health, sarcopenia, and GLP-1-associated muscle loss.

  • StroVia™ – a natural metabolism and strength-enhancing formula now commercially launched in Canada.

  • OliQuell™ – a patented olive-waste-based functional platform for air purification and circular economy applications.

  • BioPropello™ – a biostimulant improving protein synthesis and stress resilience in agriculture.

Veos is GMP-compliant, IP-driven, and regulatory-ready, with active approvals under GRAS, EFSA, and Health Canada. Our business model is B2B licensing, partnering with global leaders in consumer health, pharma, and food.

We are operational in North America, the EU, and expanding into Asia through strategic alliances

Social media

Representatives

Bassam Damaj

President

Veos Pharmaceuticals, SL